PTAB

IPR2017-01526

Mylan Pharmaceuticals Inc., v. Sanofi Aventis Deutschland GmbH

Please sign up or log in to access the advanced features of
Ex Parte Enterprise.

General

Filed

06/05/17

Institution12/13/17

FWD12/12/18

Close12/12/18

StatusFinal Written Decision

OutcomeUnpatentable

Appeals

Administrative Patent Judges

Please sign up or log in to access the advanced features of
Ex Parte Professional.

Judge	Cases	Inst. Rate	FWD Inv. Rate
Erica A Franklin	500+	50%	50%
Roberta Pollock	500+	50%	50%
Michelle N Ankenbrand	500+	50%	50%

Petitioner

Please sign up or log in to access the advanced features of
Ex Parte Professional.

Party

Name	Ratings
Mylan Pharmaceuticals Inc	L5 A
Biocon Ltd	L1 B

No Parties

Attorney

Name	Ratings
Wilson Sonsini Goodrich & Rosati	L5 A
Patrick J. Coyne	L5 A
Neal S. Cohen	L5 A
Peter Kinsella	L5 A
Scott E. Holwick	L5 A
Robert D. Bajefsky	L5 A
Scott J. Popma	L5 A

No Attorneys

Respondent

Please sign up or log in to access the advanced features of
Ex Parte Professional.

Party

Name	Ratings
Sanofi-Aventis US LLC	L3 C
Sanofi Inc	L3 C

No Parties

Attorney

No Attorneys